Stonepine Capital Management, LLC 13D and 13G filings for CTI BioPharma Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-14 08:25 am Purchase |
2023-04-04 | 13G | CTI BioPharma Corp. CTIC |
Stonepine Capital Management, LLC | 7,018,046 5.300% |
1,353,946 (+23.90%) |
Filing |
| 2023-02-13 10:27 am Sale |
2022-12-31 | 13G | CTI BioPharma Corp. CTIC |
Stonepine Capital Management, LLC | 5,664,100 4.500% |
-4,090,835 (-41.94%) |
Filing |
| 2022-02-11 7:06 pm Purchase |
2021-12-31 | 13G | CTI BioPharma Corp. CTIC |
Stonepine Capital Management, LLC | 9,754,935 9.990% |
1,606,515 (+19.72%) |
Filing |
| 2021-02-12 4:26 pm Purchase |
2020-12-31 | 13G | CTI BioPharma Corp. CTIC |
Stonepine Capital Management, LLC | 8,148,420 9.990% |
4,534,820 (+125.49%) |
Filing |